United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE326.9300
- TODAY'S CHANGE (%)-0.3300 (-0.1008%)
- Bid / Lots326.5700/ 4
- Ask / Lots327.2100/ 4
- Open / Previous Close328.8900 / 327.2600
- Day Range
- 52 Week Range
- Volume128,451
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 3898 | 329.245 |
| 09:34 ET | 100 | 327.965 |
| 09:36 ET | 100 | 328.5319 |
| 09:39 ET | 100 | 328.64 |
| 09:45 ET | 421 | 328.555 |
| 09:50 ET | 100 | 328.635 |
| 09:54 ET | 1486 | 329 |
| 09:59 ET | 3655 | 329.1 |
| 10:01 ET | 6404 | 329.63 |
| 10:03 ET | 219 | 329.375 |
| 10:06 ET | 300 | 328.775 |
| 10:08 ET | 100 | 328.6775 |
| 10:10 ET | 449 | 328.44 |
| 10:14 ET | 150 | 328.4 |
| 10:17 ET | 1456 | 328.67 |
| 10:19 ET | 771 | 328.76 |
| 10:21 ET | 100 | 328.79 |
| 10:24 ET | 818 | 328.76 |
| 10:26 ET | 210 | 328.8025 |
| 10:28 ET | 2105 | 328.815 |
| 10:32 ET | 1800 | 328.02 |
| 10:33 ET | 100 | 327.57 |
| 10:39 ET | 200 | 327.66 |
| 10:42 ET | 100 | 327.805 |
| 10:46 ET | 3610 | 328.22 |
| 10:51 ET | 671 | 328.36 |
| 10:53 ET | 300 | 328.07 |
| 10:55 ET | 290 | 328.02 |
| 11:02 ET | 100 | 328.15 |
| 11:06 ET | 722 | 328.18 |
| 11:08 ET | 251 | 328.155 |
| 11:11 ET | 1200 | 328.37 |
| 11:13 ET | 900 | 328.3 |
| 11:15 ET | 1299 | 329.055 |
| 11:18 ET | 500 | 328.975 |
| 11:22 ET | 620 | 328.935 |
| 11:26 ET | 100 | 328.61 |
| 11:29 ET | 300 | 328.7 |
| 11:31 ET | 609 | 328.57 |
| 11:40 ET | 600 | 328.765 |
| 11:42 ET | 200 | 328.775 |
| 11:44 ET | 100 | 328.54 |
| 11:45 ET | 100 | 328.655 |
| 11:47 ET | 400 | 328.56 |
| 11:49 ET | 634 | 328.65 |
| 11:51 ET | 100 | 328.775 |
| 11:56 ET | 100 | 328.66 |
| 11:58 ET | 200 | 328.775 |
| 12:00 ET | 612 | 328.66 |
| 12:03 ET | 100 | 328.65 |
| 12:05 ET | 515 | 328.694 |
| 12:07 ET | 490 | 328.52 |
| 12:09 ET | 792 | 327.655 |
| 12:12 ET | 200 | 327.76 |
| 12:14 ET | 300 | 327.865 |
| 12:16 ET | 252 | 327.865 |
| 12:18 ET | 678 | 327.785 |
| 12:20 ET | 200 | 328.07 |
| 12:23 ET | 277 | 328.22 |
| 12:25 ET | 104 | 328.07 |
| 12:30 ET | 900 | 328.075 |
| 12:32 ET | 100 | 328.055 |
| 12:36 ET | 252 | 328.065 |
| 12:38 ET | 300 | 328.09 |
| 12:39 ET | 500 | 327.86 |
| 12:43 ET | 100 | 327.74 |
| 12:45 ET | 400 | 327.56 |
| 12:56 ET | 200 | 327.16 |
| 12:57 ET | 305 | 327.195 |
| 12:59 ET | 300 | 327.82 |
| 01:01 ET | 400 | 327.58 |
| 01:08 ET | 419 | 327.36 |
| 01:12 ET | 100 | 327.505 |
| 01:14 ET | 200 | 327.36 |
| 01:15 ET | 200 | 327.45 |
| 01:17 ET | 200 | 327.445 |
| 01:24 ET | 100 | 327.485 |
| 01:26 ET | 1600 | 327.75 |
| 01:28 ET | 1505 | 327.34 |
| 01:30 ET | 2778 | 327.15 |
| 01:32 ET | 400 | 327.26 |
| 01:33 ET | 100 | 327.23 |
| 01:35 ET | 200 | 327.19 |
| 01:37 ET | 400 | 327.115 |
| 01:42 ET | 100 | 327.14 |
| 01:44 ET | 200 | 327.32 |
| 01:48 ET | 200 | 327.29 |
| 01:51 ET | 100 | 327.245 |
| 01:53 ET | 500 | 327.035 |
| 01:57 ET | 400 | 326.375 |
| 02:00 ET | 121 | 326.555 |
| 02:04 ET | 2700 | 326.455 |
| 02:06 ET | 1700 | 326.455 |
| 02:08 ET | 600 | 326.64 |
| 02:09 ET | 1000 | 326.93 |
Jul 11, 2024
DJ United Therapeutics Is Maintained at Buy by TD Cowen, from 8:05AM ET on Thursday Jul 11, 2024 by Dow Jones
8:05AM ET on Thursday Jul 11, 2024 by Dow JonesDJ United Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley, from 5:37AM ET on Thursday Jul 11, 2024 by Dow Jones
5:37AM ET on Thursday Jul 11, 2024 by Dow Jones
Jul 10, 2024
Jul 8, 2024
DJ United Therapeutics Is Maintained at Buy by UBS, from 12:05PM ET on Monday Jul 08, 2024 by Dow Jones
12:05PM ET on Monday Jul 08, 2024 by Dow Jones
Jun 27, 2024
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors, from 7:00AM ET on Thursday Jun 27, 2024 by Dow Jones
7:00AM ET on Thursday Jun 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 14.5B | 15.5x | +8.22% |
Biomarin Pharmaceutical Inc | 16.1B | 79.6x | --- |
Beigene Ltd | 16.4B | -20.3x | --- |
Neurocrine Biosciences Inc | 14.8B | 40.8x | +62.04% |
Medpace Holdings Inc | 13.8B | 46.1x | +35.10% |
Exact Sciences Corp | 8.7B | -37.4x | --- |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.5B |
|---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 44.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.55 |
EPS | $21.13 |
Book Value | $127.23 |
P/E Ratio | 15.5x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | 13.1x |
Operating Margin | 50.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
